Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Esomeprazole strontium/naproxen - Hanmi Pharmaceutical

Next Previous
X
Search
Drug Profile

Esomeprazole strontium/naproxen - Hanmi Pharmaceutical

Alternative Names: HCP-1004; Naproxen/esomeprazole strontium - Hanmi Pharmaceutical

Latest Information Update: 21 Nov 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Hanmi Pharmaceutical
  • Class 2 pyridinylmethylsulfinylbenzimidazoles; Anti-inflammatories; Antirheumatics; Naphthaleneacetic acids; Nonsteroidal anti-inflammatories; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors; Prostaglandin synthase inhibitors; Proton pump inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Back pain
  • Clinical Phase Unknown Rheumatoid arthritis

Most Recent Events

  • 07 Nov 2024 Phase-III clinical trials in Back pain in South Korea (PO) (NCT06595004)
  • 01 Oct 2024 Hanmi Pharmaceutical plans phase-III trial for Back pain in October 2024 (PO, Tablet), (NCT06595004)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top